🇺🇸 FDA
Patent

US 11045478

Salts of potassium ATP channel openers and uses thereof

granted A61KA61K31/54A61K31/549

Quick answer

US patent 11045478 (Salts of potassium ATP channel openers and uses thereof) held by ESSENTIALIS, INC. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ESSENTIALIS, INC.
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/54, A61K31/549, A61K38/27, A61K45/06